StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a research note issued to investors on Wednesday. The firm issued a buy rating on the stock.
Mannatech Stock Performance
NASDAQ:MTEX opened at $8.16 on Wednesday. The company has a current ratio of 1.07, a quick ratio of 0.51 and a debt-to-equity ratio of 0.09. The firm has a 50-day moving average price of $8.63 and a two-hundred day moving average price of $8.78. Mannatech has a twelve month low of $7.50 and a twelve month high of $15.10. The company has a market capitalization of $15.38 million, a P/E ratio of -6.80 and a beta of 1.20.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings results on Thursday, March 28th. The company reported ($0.94) EPS for the quarter. The firm had revenue of $32.69 million for the quarter. Mannatech had a negative return on equity of 19.19% and a negative net margin of 1.70%.
About Mannatech
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Featured Articles
- Five stocks we like better than Mannatech
- Basic Materials Stocks Investing
- High-Yield Texas Instruments Could Hit New Highs Soon
- What is the Shanghai Stock Exchange Composite Index?
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Bank Stocks – Best Bank Stocks to Invest In
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.